Trial NCT02881567

View at ClinicalTrials.gov 
Org. Study IDs: 205MS305
Secondary IDs: 2016-002820-10

Last trial update was posted on 2019-09-27

MeSH Interventions

Daclizumab

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Sclerosis

Other Conditions

Relapsing-Remitting Multiple Sclerosis (RRMS)

Stopping Reasons

Study terminated in line with Biogen decision to withdraw Zinbryta from the market and not to pursue further studies of daclizumab in MS.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID